Wasatch Advisors LP Has $719.01 Million Holdings in HealthEquity, Inc. $HQY

Wasatch Advisors LP boosted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 10.5% during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 7,960,735 shares of the company’s stock after buying an additional 757,801 shares during the period. HealthEquity makes up approximately 4.7% of Wasatch Advisors LP’s holdings, making the stock its biggest holding. Wasatch Advisors LP owned 9.52% of HealthEquity worth $719,014,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the stock. Sivia Capital Partners LLC bought a new stake in shares of HealthEquity during the second quarter worth $306,000. Arrowstreet Capital Limited Partnership bought a new stake in HealthEquity in the 2nd quarter valued at $4,747,000. Marshall Wace LLP bought a new stake in HealthEquity in the 2nd quarter valued at $5,483,000. Amundi boosted its stake in HealthEquity by 9.3% in the 2nd quarter. Amundi now owns 30,203 shares of the company’s stock worth $3,059,000 after purchasing an additional 2,574 shares during the period. Finally, Jump Financial LLC acquired a new position in HealthEquity in the 2nd quarter worth $449,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Trading Down 1.1%

Shares of NASDAQ:HQY opened at $105.57 on Wednesday. The company’s 50-day moving average price is $94.03 and its two-hundred day moving average price is $86.10. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $107.62. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. The stock has a market capitalization of $8.83 billion, a PE ratio of 39.54, a price-to-earnings-growth ratio of 1.80 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. The company’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, equities analysts forecast that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Analyst Ratings Changes

HQY has been the subject of a number of research reports. KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. BTIG Research boosted their price target on HealthEquity from $110.00 to $115.00 and gave the company a “buy” rating in a report on Friday, July 24th. Royal Bank Of Canada upped their price objective on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a research report on Wednesday, June 3rd. Weiss Ratings upgraded HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, June 5th. Finally, Citizens Jmp lifted their target price on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research report on Monday, June 1st. Eleven research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and a consensus price target of $110.93.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the transaction, the executive vice president owned 59,113 shares of the company’s stock, valued at $5,615,735. The trade was a 5.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the sale, the director owned 19,733 shares in the company, valued at approximately $1,775,970. This represents a 11.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 17,905 shares of company stock worth $1,651,280 over the last ninety days. 1.60% of the stock is currently owned by corporate insiders.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.